M.A. Pizzoleo

695 total citations
11 papers, 534 citations indexed

About

M.A. Pizzoleo is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, M.A. Pizzoleo has authored 11 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in M.A. Pizzoleo's work include Bone health and treatments (3 papers), Bone health and osteoporosis research (3 papers) and Bone Metabolism and Diseases (3 papers). M.A. Pizzoleo is often cited by papers focused on Bone health and treatments (3 papers), Bone health and osteoporosis research (3 papers) and Bone Metabolism and Diseases (3 papers). M.A. Pizzoleo collaborates with scholars based in Italy. M.A. Pizzoleo's co-authors include N Frisina, Antonino Lasco, Agostino Gaudio, Maria Cincotta, Nunziata Morabito, Alessandra Crisafulli, Francesco Corrado, Domenica Altavilla, Riccardo Ientile and Francesco Squadrito and has published in prestigious journals such as Journal of Bone and Mineral Research, Osteoporosis International and Thrombosis Research.

In The Last Decade

M.A. Pizzoleo

11 papers receiving 507 citations

Peers

M.A. Pizzoleo
J. Birmingham Australia
Khe Ni United States
R.W. Retallack Australia
CHARLES H. BURNETT United States
Brian Durham United Kingdom
Uģis Gruntmanis United States
J. Birmingham Australia
M.A. Pizzoleo
Citations per year, relative to M.A. Pizzoleo M.A. Pizzoleo (= 1×) peers J. Birmingham

Countries citing papers authored by M.A. Pizzoleo

Since Specialization
Citations

This map shows the geographic impact of M.A. Pizzoleo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Pizzoleo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Pizzoleo more than expected).

Fields of papers citing papers by M.A. Pizzoleo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Pizzoleo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Pizzoleo. The network helps show where M.A. Pizzoleo may publish in the future.

Co-authorship network of co-authors of M.A. Pizzoleo

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Pizzoleo. A scholar is included among the top collaborators of M.A. Pizzoleo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Pizzoleo. M.A. Pizzoleo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Trifiletti, A, Agostino Gaudio, Antonino Lasco, et al.. (2008). Haemostatic effects of phytoestrogen genistein in postmenopausal women. Thrombosis Research. 123(2). 231–235. 6 indexed citations
2.
Crisafulli, Alessandra, Adolfo Romeo, Fulvio Floccari, et al.. (2005). Osteoprotegerin and Bone Mineral Density in Hemodiafiltration Patients. Renal Failure. 27(5). 531–539. 14 indexed citations
3.
Morabito, Nunziata, Agostino Gaudio, Antonino Lasco, et al.. (2004). Osteoprotegerin and RANKL in the Pathogenesis of Thalassemia-Induced Osteoporosis: New Pieces of the Puzzle. Journal of Bone and Mineral Research. 19(5). 722–727. 97 indexed citations
4.
Trifiletti, A, Antonino Lasco, M.A. Pizzoleo, et al.. (2003). Long-Term Hemostatic Effects of Cholesterol-Lowering Therapy with Atorvastatin. Pathophysiology of Haemostasis and Thrombosis. 33(2). 84–87. 7 indexed citations
5.
Morabito, N., Agostino Gaudio, Antonino Lasco, et al.. (2003). Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis. Osteoporosis International. 14(6). 500–506. 23 indexed citations
6.
Morabito, Nunziata, Alessandra Crisafulli, Agostino Gaudio, et al.. (2002). Effects of Genistein and Hormone-Replacement Therapy on Bone Loss in Early Postmenopausal Women: A Randomized Double-Blind Placebo-Controlled Study. Journal of Bone and Mineral Research. 17(10). 1904–1912. 336 indexed citations
7.
Trifiletti, A, et al.. (2001). Increased Indexes of Thrombin Activation in Advanced Stages of Hypertension. Pathophysiology of Haemostasis and Thrombosis. 31(1). 49–54. 9 indexed citations
8.
Trifiletti, A, et al.. (1999). Clinical and haemostatic effects of intravenous prostaglandin E1 therapy in patients with peripheral arterial occlusive disease.. PubMed. 41(1). 15–7. 1 indexed citations
9.
Trifiletti, A, et al.. (1997). Effects of Medium-Term Antihypertensive Therapy on Haemostatic Parameters in Patients with Essential Hypertension. Pathophysiology of Haemostasis and Thrombosis. 27(1). 35–38. 16 indexed citations
10.
Trifiletti, A, et al.. (1995). Haemostatic Variables in Arterial Hypertension. Pathophysiology of Haemostasis and Thrombosis. 25(5). 237–240. 13 indexed citations
11.
Trifiletti, A, et al.. (1995). Hemostatic disorders associated with arterial hypertension and peripheral arterial disease.. PubMed. 36(5). 483–5. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026